‘No from us’: Antipodes avoids SpaceX but likes this AI stock instead

Vihari Ross talks about the market’s hottest IPO, where she’s spotting opportunity to ride the chip boom and why she cashed out of Hyundai.

Grace Lagan

‘No from us’: Antipodes avoids SpaceX but likes this AI stock instead

June 11, 2026
Vihari Ross talks about the market’s hottest IPO, where she’s spotting opportunity to ride the chip boom and why she cashed out of Hyundai.
Read Transcript

Vihari Ross is a portfolio manager overseeing global equities at Antipodes Partners. The Sydney-based firm oversees $20.6 billion in assets under management.

The global portfolios have posted strong returns in the past 12 months – do you think any of your past winners have further to run?

In the context of market broadening over the past year, followed by the recent extreme crowding into hardware, the returns have come from broad and unique sources, with precious metals, auto, senior housing, healthcare, energy, electric grid, and technology and hardware supply-chain companies among the top contributors.

Many of these positions have since been actively recycled, and capital has been deployed into new ideas the team has generated.

Each stock must earn its place and has a job to do, so in that sense, we continue to see strong return opportunities across our global portfolios.

Our portfolios have been positioned for market breadth to widen and extreme valuation dispersion to close, and that hasn’t changed.

We’re targeting opportunities across software-as-a-service disruption from artificial intelligence, energy services, materials, infrastructure, healthcare innovation, and [artificial intelligence] enablers and adopters.

Thoughts on the SpaceX initial public offering slated for Friday? Is Antipodes planning to buy in? 

The IPO has been marketed aggressively, especially to retail investors, with index inclusion negotiations under way too.

There will be significant oversubscription, which introduces the classic popularity-contest dynamic that can drive short-term price performance.

Elon Musk is a visionary founder with majority control, and while making life interplanetary and providing Wi-Fi to Martian cities sounds very cool, the majority of the company’s proposed full market potential remains more conceptual than tangible. It’s a no from us.

What’s a position you’ve exited recently and why?

We exited Hyundai Motor earlier in the year. The company still has growth opportunities across its internal combustion engine, hybrid and electric vehicle ranges, has a strong balance sheet, and can be a beneficiary of the South Korean government’s corporate governance clean-up.

However, it rallied over 100 per cent within a few months and reached our valuation target, driven by investor enthusiasm for its AI and robotics strategy.

With the relative risk-reward shifting, it was time to recycle that capital into other opportunities.

What’s a stock you own that (most) investors haven’t heard of?

One we’ve held since mid-last year is Japanese chemicals company Shin-Etsu Chemical. It’s a global leader operating in consolidated markets with high barriers to entry.

It’s the leading player in producing the polysilicon wafer, which is standard in the manufacture of the advanced nodes used in microchips. Demand spans autos, gaming, smartphones, PCs and data centres, with AI now a structural driver.

There is a cyclical opportunity in materials like PVC and silicons, and the company is at the bottom of the global cost curve.

It will benefit from a recovery in US housing and via use across construction, autos, electronics, and healthcare.

Which stock in your fund is the most undervalued by the market?

In the current market, there is compelling value across many cyclical, real-asset industries.

SLB is one example. It’s an oil services opportunity linked to the cyclical recovery in capital expenditure on exploration.

As the leading technology, software, and equipment provider to oil majors specialising in large, technically complex offshore and subsea projects, SLB is well placed to benefit from an industry at a favourable inflection point in capex following a decade of decline, with the shift away from shale towards offshore and liquefied natural gas playing to its strengths.

Its digital division provides proprietary AI tools and has faster growth and nearly double the margins of the company’s core segments, and new energy exposure across carbon capture, hydrogen, and geothermal adds optionality.

It trades at a discount to history on trough earnings, having traded at a market premium pre-COVID.

Meanwhile, about 10 per cent of market capitalisation is returned annually through buybacks and dividends, offering investors a well-compensated wait for the upgrade cycle to play out.

What one piece of advice has influenced your approach to investing?

The one certainty in markets and industries is that things will change. So pay attention to the impact of change and the resilience of a company to that change.

Markets often act irrationally when it comes to extrapolating change, treating a cycle low or speculative high as permanent.

This leads to value opportunities across both cyclical recovery stories and structural growers, and will help avoid those “cheap for a reason” value traps as well as the over-extended growth traps.

Are there any books, podcasts or TV shows that you’d recommend?

I quite like the Acquired podcast. Each one is a bit of a time commitment, but it’s really well-researched, enthusiastically presented and gets into the history lesson of the strategy and the luck behind how the world’s most successful companies came to be.

What is your favourite local bar/restaurant?

The front bar at Fred’s in Paddington does a great martini!

Vihari Ross is a portfolio manager overseeing global equities at Antipodes Partners. The Sydney-based firm oversees $20.6 billion in assets under management.

The global portfolios have posted strong returns in the past 12 months – do you think any of your past winners have further to run?

In the context of market broadening over the past year, followed by the recent extreme crowding into hardware, the returns have come from broad and unique sources, with precious metals, auto, senior housing, healthcare, energy, electric grid, and technology and hardware supply-chain companies among the top contributors.

Many of these positions have since been actively recycled, and capital has been deployed into new ideas the team has generated.

Each stock must earn its place and has a job to do, so in that sense, we continue to see strong return opportunities across our global portfolios.

Our portfolios have been positioned for market breadth to widen and extreme valuation dispersion to close, and that hasn’t changed.

We’re targeting opportunities across software-as-a-service disruption from artificial intelligence, energy services, materials, infrastructure, healthcare innovation, and [artificial intelligence] enablers and adopters.

Thoughts on the SpaceX initial public offering slated for Friday? Is Antipodes planning to buy in? 

The IPO has been marketed aggressively, especially to retail investors, with index inclusion negotiations under way too.

There will be significant oversubscription, which introduces the classic popularity-contest dynamic that can drive short-term price performance.

Elon Musk is a visionary founder with majority control, and while making life interplanetary and providing Wi-Fi to Martian cities sounds very cool, the majority of the company’s proposed full market potential remains more conceptual than tangible. It’s a no from us.

What’s a position you’ve exited recently and why?

We exited Hyundai Motor earlier in the year. The company still has growth opportunities across its internal combustion engine, hybrid and electric vehicle ranges, has a strong balance sheet, and can be a beneficiary of the South Korean government’s corporate governance clean-up.

However, it rallied over 100 per cent within a few months and reached our valuation target, driven by investor enthusiasm for its AI and robotics strategy.

With the relative risk-reward shifting, it was time to recycle that capital into other opportunities.

What’s a stock you own that (most) investors haven’t heard of?

One we’ve held since mid-last year is Japanese chemicals company Shin-Etsu Chemical. It’s a global leader operating in consolidated markets with high barriers to entry.

It’s the leading player in producing the polysilicon wafer, which is standard in the manufacture of the advanced nodes used in microchips. Demand spans autos, gaming, smartphones, PCs and data centres, with AI now a structural driver.

There is a cyclical opportunity in materials like PVC and silicons, and the company is at the bottom of the global cost curve.

It will benefit from a recovery in US housing and via use across construction, autos, electronics, and healthcare.

Which stock in your fund is the most undervalued by the market?

In the current market, there is compelling value across many cyclical, real-asset industries.

SLB is one example. It’s an oil services opportunity linked to the cyclical recovery in capital expenditure on exploration.

As the leading technology, software, and equipment provider to oil majors specialising in large, technically complex offshore and subsea projects, SLB is well placed to benefit from an industry at a favourable inflection point in capex following a decade of decline, with the shift away from shale towards offshore and liquefied natural gas playing to its strengths.

Its digital division provides proprietary AI tools and has faster growth and nearly double the margins of the company’s core segments, and new energy exposure across carbon capture, hydrogen, and geothermal adds optionality.

It trades at a discount to history on trough earnings, having traded at a market premium pre-COVID.

Meanwhile, about 10 per cent of market capitalisation is returned annually through buybacks and dividends, offering investors a well-compensated wait for the upgrade cycle to play out.

What one piece of advice has influenced your approach to investing?

The one certainty in markets and industries is that things will change. So pay attention to the impact of change and the resilience of a company to that change.

Markets often act irrationally when it comes to extrapolating change, treating a cycle low or speculative high as permanent.

This leads to value opportunities across both cyclical recovery stories and structural growers, and will help avoid those “cheap for a reason” value traps as well as the over-extended growth traps.

Are there any books, podcasts or TV shows that you’d recommend?

I quite like the Acquired podcast. Each one is a bit of a time commitment, but it’s really well-researched, enthusiastically presented and gets into the history lesson of the strategy and the luck behind how the world’s most successful companies came to be.

What is your favourite local bar/restaurant?

The front bar at Fred’s in Paddington does a great martini!

Disclaimer: This material has been prepared by Australian Financial Review, published on June 11, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 25, 2026

Finding the edge: data, AI and active investing

Markets are moving faster than ever. AI is changing how investment managers research, think and ultimately make decisions. Hear from Magellan on finding the edge and knowing how to use it.

Read More
May 31, 2026

Munro Partners’ Nick Griffin on picking the few winners and avoiding the losers in global equities

Nick explains why his team focuses on investing in structurally growing companies and the main characteristics to look for in identifying those that will be the long-term winners. Nick also shares his views on structural themes that are providing the tailwinds from which winners will emerge.

Read More
June 11, 2026

Plato, Munro invest in SpaceX as rival funds wait for the sellers

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

Read More
March 3, 2025

The investing megatrends you can’t ignore (and some you should rethink)

James Marlay of Livewire sat down with Vihari Ross of Antipodes (HM1 Conference Fund Manager) and James Tsinidis of Munro Partners (HM1 Core Fund Manager) to discuss the biggest megatrends shaping the future.

Read More
January 6, 2025

Resources fundies reveal top picks ahead of ‘stellar’ 2025

Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.

Read More
December 28, 2024

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors.

Read More
November 26, 2024

How Trump will impact equity markets

The United States has spoken. President Trump has returned to the White House. But how can we cut through the noise to reveal the investment, economic and geopolitical ramifications?

Read More
Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.
November 18, 2024

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
Tech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben SearcyTech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben SearcyTech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben SearcyTech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben Searcy
November 15, 2024

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
September 16, 2024

With Purpose podcast with Michael Traill

Tune in to hear from Michael Traill AM, Executive Director of For Purpose Investment Partners, Chair of the Paul Ramsay Foundation, and HM1 Board Director.

Read More
June 19, 2024

Nvidia became the biggest company in the world. Now what?

Now that Nvidia has reached the milestone of becoming the biggest company in the world, what does its future hold?

Read More
June 11, 2024

Nine stocks to buy and hold forever

The younger the investor, the more time they have to earn life-changing capital gains by staying invested in the market over the long term.

Read More
June 2, 2024

What's next for Guzman y Gomez?

Equity Mates recently spoke with Guzman y Gomez co-CEOs Steven Marks and Hilton Brett to talk about what next for the Mexican quick service restaurant giant now that they have joined the ASX.

Read More
April 30, 2024

Magellan decode the Magnificent Seven

Get the latest insights from Magellan on the Magnificent 7 (NVIDIA, Meta, Tesla, Amazon, Microsoft, Alphabet Inc. Apple) including profitability, fundamentals and the future.

Read More
February 26, 2024

Chipping away at the semiconductor market

In a recent episode of In The Know, the team at Magellan discuss the outlook for the Semiconductor chip industry covering many stocks in HM1's portfolio including their recommended stock for our core portfolio.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.